Jan M Langrehr
Overview
Explore the profile of Jan M Langrehr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
783
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bahra M, Jacob D, Pascher A, Plockinger U, Kristiansen G, Neuhaus P, et al.
J Gastroenterol Hepatol
. 2007 May;
22(6):930-5.
PMID: 17489964
Background And Aim: Neuroendocrine pancreatic carcinomas are rare and little information on factors influencing the clinical course and prognosis is presently available. The aim of this study was to retrospectively...
12.
Hildebrandt B, Pech M, Nicolaou A, Langrehr J, Kurcz J, Bartels B, et al.
BMC Cancer
. 2007 Apr;
7:69.
PMID: 17456240
Background: The high complication rates of surgically implanted port catheter systems (SIPCS) represents a major drawback in the treatment of isolated liver neoplasms by hepatic arterial infusion (HAI) of chemotherapy....
13.
Jacob D, Bahra M, Langrehr J, Boas-Knoop S, Stefaniak R, Davis J, et al.
J Gastroenterol Hepatol
. 2007 Apr;
22(5):738-48.
PMID: 17444865
Background And Aim: Poly (ADP-ribose) polymerase (PARP) inhibitors such as 3-aminobenzamide (3-ABA) enhance the in vitro cytotoxicity of DNA mono-functional alkylating agents such as radiation or chemotherapeutic agents. The aim...
14.
Bahra M, Neumann U, Jacob D, Langrehr J, Berg T, Neuhaus R, et al.
Transplantation
. 2007 Feb;
83(3):351-3.
PMID: 17297412
The rate of fibrosis progression was analyzed in 28 hepatitis C virus-infected liver graft recipients showing sustained virologic response after treatment with ribavirin plus either standard interferon alpha-2b (n=8), pegylated...
15.
Friess H, Langrehr J, Oettle H, Raedle J, Niedergethmann M, Dittrich C, et al.
BMC Cancer
. 2006 Dec;
6:285.
PMID: 17156477
Background: Anti-angiogenic treatment is believed to have at least cystostatic effects in highly vascularized tumours like pancreatic cancer. In this study, the treatment effects of the angiogenesis inhibitor Cilengitide and...
16.
Kristiansen G, Jacob J, Buckendahl A, Grutzmann R, Alldinger I, Sipos B, et al.
Clin Cancer Res
. 2006 Nov;
12(21):6444-51.
PMID: 17085658
Purpose: Peroxisome proliferator-activated receptor gamma (PPARgamma) is a ligand-activated transcription factor that has been implicated in carcinogenesis and progression of various solid tumors, including pancreatic carcinoma. We aimed to clarify...
17.
Jacob D, Bahra M, Langrehr J
Surg Today
. 2006 Sep;
36(10):898-907.
PMID: 16998684
Purpose: Perioperative mortality after pancreatic head resection has fallen to below 5% in high-volume centers, but dehiscence of the pancreatojejunostomy remains a major concern. Despite various methods of protection, insufficiency...
18.
Langrehr J, Klupp J, Glanemann M, Junge G, Pfitzmann R, Bahra M, et al.
Clin Transplant
. 2006 Jul;
20(3):272-83.
PMID: 16824141
Background: The addition of mycophenolate mofetil (MMF) to the induction protocol resulted in a lower incidence of rejection episodes. However, the question whether MMF should be administered in combination with...
19.
Jacob D, Neumann U, Bahra M, Klupp J, Puhl G, Neuhaus R, et al.
Clin Transplant
. 2006 Apr;
20(2):211-20.
PMID: 16640529
Orthotopic liver transplantation (OLT) is the only effective curative therapy for end-stage primary biliary cirrhosis (PBC). Survival after OLT is excellent, although recent data have shown a recurrence rate of...
20.
Spinelli A, Schumacher G, Pascher A, Lopez-Hanninen E, Al-Abadi H, Benckert C, et al.
World J Gastroenterol
. 2006 Apr;
12(14):2293-6.
PMID: 16610041
Xanthogranulomatous cholecystitis (XGC) is a destructive inflammatory disease of the gallbladder, rarely involving adjacent organs and mimicking an advanced gallbladder carcinoma. The diagnosis is usually possible only after pathological examination....